Biomarkers for ovarian cancer: New technologies and targets to address persistently unmet needs

被引:4
作者
Bast, Robert C., Jr. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Unit 1439, Dept Expt Therapeut, Houston, TX 77030 USA
关键词
MARKERS;
D O I
10.3233/CBM-2011-0209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:161 / 166
页数:6
相关论文
共 31 条
  • [1] Glycomic analysis of ovarian cancer: Past, present, and future
    Abbott, Karen L.
    [J]. CANCER BIOMARKERS, 2010, 8 (4-5) : 273 - 280
  • [2] Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry
    Adolphi, Natalie L.
    Huber, Dale L.
    Bryant, Howard C.
    Monson, Todd C.
    Fegan, Danielle L.
    Lim, JitKang
    Trujillo, Jason E.
    Tessier, Trace E.
    Lovato, Debbie M.
    Butler, Kimberly S.
    Provencio, Paula P.
    Hathaway, Helen J.
    Majetich, Sara A.
    Larson, Richard S.
    Flynn, Edward R.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2010, 55 (19) : 5985 - 6003
  • [3] Urinary levels of Bcl-2 are elevated in ovarian cancer patients
    Anderson, Nicole S.
    Bermudez, Yira
    Badgwell, Donna
    Chen, Ren
    Nicosia, Santo V.
    Bast, Robert C., Jr.
    Kruk, Patricia A.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 60 - 67
  • [4] [Anonymous], [No title captured]
  • [5] Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
    Badgwell, Donna
    Lu, Zhen
    Cole, Laurence
    Fritsche, Herbert
    Atkinson, Edward N.
    Somers, Elizabeth
    Allard, Jeffrey
    Moore, Richard G.
    Lu, Karen H.
    Bast, Robert C., Jr.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 106 (03) : 490 - 497
  • [6] The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer
    Balch, Curtis
    Nephew, Kenneth P.
    [J]. CANCER BIOMARKERS, 2010, 8 (4-5) : 203 - 221
  • [7] Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond
    Bast, Robert C., Jr.
    Mills, Gordon B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3545 - 3548
  • [8] The biology of ovarian cancer: new opportunities for translation
    Bast, Robert C., Jr.
    Hennessy, Bryan
    Mills, Gordon B.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (06) : 415 - 428
  • [9] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [10] Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
    Bookman, Michael A.
    Brady, Mark F.
    McGuire, William P.
    Harper, Peter G.
    Alberts, David S.
    Friedlander, Michael
    Colombo, Nicoletta
    Fowler, Jeffrey M.
    Argenta, Peter A.
    De Geest, Koen
    Mutch, David G.
    Burger, Robert A.
    Swart, Ann Marie
    Trimble, Edward L.
    Accario-Winslow, Chrisann
    Roth, Lawrence M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1419 - 1425